Physician
Hematology
Dr. Camille L. Bedrosian, MD
Camille Bedrosian practices Hematology. He researched medicine at Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School is ranked 1 in research and 12 in primary care medicine Camille L. Bedrosian, MD has written publications. He has 19 publications published with PubMed. The lastest paper is: 'Use of peripheral nerve stimulators to monitor patients with neuromuscular blockade in the ICU.'
Publications
- Analysis of the pharmacodynamic activity of the mTOR inhibitor ridaforolimus (AP23573, MK-8669) in a phase 1 clinical trial.
- Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS clinical trial.
- A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malign...
- Phase I trial of the novel mammalian target of rapamycin inhibitor deforolimus (AP23573; MK-8669) administered intravenously daily for 5 days every 2 weeks to patients...
- A phase I trial to determine the safety, tolerability, and maximum tolerated dose of deforolimus in patients with advanced malignancies.
- Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters.
- Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants.
- Use of peripheral nerve stimulators to monitor patients with neuromuscular blockade in the ICU.
- A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
- Arsenic poisoning and seizures.
- Antifibrinolytic therapy in the management of the Kasabach Merritt syndrome.
- Cold hemagglutinin disease in the operating room.
- Peripheral T-cell lymphoma complicating common variable hypogammaglobulinemia.
- The DNA-binding domain of HPV-16 E2 protein interaction with the viral enhancer: protein-induced DNA bending and role of the nonconserved core sequence in binding site...
- Escherichia coli replication terminator protein impedes simian virus 40 (SV40) DNA replication fork movement and SV40 large tumor antigen helicase activity in vitro at...
- The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A.
- Clinical evaluation of B-domain deleted recombinant factor VIII in previously untreated patients.
- Clinical evaluation of B-domain deleted recombinant factor VIII in previously treated patients.
Schools
Harvard Medical School
Doctors Specialties
- Internal Medicine
- Hematology
Accepted Insurances
Education
-
Duke University Hospital -
Harvard Medical School
Hospital
-
Duke University Hospital
Helpful Reviews
Similar Doctors
|
Dr. Thomas Caughey, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew R. Kaufman, MD |
|
|
Dr. Teresa L. Schraeder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Austin Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hao Wang, MD |
|
|
Dr. Roberto Mattii, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Burt A. Adelman, MD |
|
|
Dr. Elizabet Kwo, MD |
|
|
Dr. Mahmoud A. Moawad Elnaa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leann R. Canty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose A. Halperin, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ellen J. Schwartz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Danny McCormick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yamini Saravanan, MD
This Doctor is OpenDoctor Recommended.
|